Skip to main content
. 2020 Jul 29:10.2217/nnm-2020-0247. doi: 10.2217/nnm-2020-0247

Figure 2. Clinical phase vaccine candidates for the coronavirus disease 2019.

Figure 2.

aAPC: Artificial antigen-presenting cells; Ad5-nCoV: Adenovirus Type 5 vectored COVID-19 vaccine; DC: Dendritic cell; LNP: Lipid nanoparticles; LV: Lentiviral vector; S: Spike; SARS-CoV-2: Severe acute respiratory syndrome coronavirus-2.